Physician profile
Edith Bostic
NPI 1235773326
$2,115.12
in general payments reported to CMS, 2019-2025
12 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.34 · 2023: $970 · 2024: $997 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,090 · Education: $9.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,090.13 |
| Education | $9.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $532.23 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $491.90 | 2021-2024 | Spravato, Invega Sustenna |
| Vanda Pharmaceuticals INC. | $252.50 | 2023-2025 | Fanapt, Hetlioz |
| Axsome Therapeutics, INC. | $217.06 | 2023-2025 | Auvelity |
| Lundbeck LLC | $130.50 | 2023-2024 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $119.24 | 2023-2025 | Rexulti, Abilify Maintena |
| Alkermes, INC. | $107.28 | 2023-2024 | Lybalvi, Vivitrol |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $89.87 | 2023-2024 | Caplyta |
| Neurocrine Biosciences, INC. | $85.96 | 2023-2024 | Ingrezza |
| Ironshore Pharmaceuticals INC. | $43.65 | 2023-2024 | Jornay Pm |
| Teva Pharmaceuticals USA, INC. | $24.31 | 2023 | Austedo Xr |
| Tris Pharma INC | $20.62 | 2024 | Dyanavel Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edith Bostic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.